 |
|
Postmarketing Surveillance Study of the Efficacy and Safety of Phentermine in Patients with Obesity
Hyun Ok Kim, Jung Ah Lee, Hee Won Suh, Young Sik Kim, Bum Soo Kim, Eun Sook Ahn, Young Jun Roh, Seong Gil Jung, Jin Mok Kim, Moon Kuk Kang, In Soon Ahn, Young Gyu Park
Korean J Fam Med. 2013;34(5):298-306. Published online 2013 Sep 26 DOI: https://doi.org/10.4082/kjfm.2013.34.5.298
|
|
Citations to this article as recorded by
 Phentermine in the Modern Era of Obesity Pharmacotherapy: Does It Still Have a Role in Treatment?
Kristina H. Lewis, Kimberly A. Gudzune, Jamy D. Ard
Current Obesity Reports.2024; 13(1): 132. CrossRef Effectiveness and safety of drugs for obesity
Kristina Henderson Lewis, Caroline E Sloan, Daniel H Bessesen, David Arterburn
BMJ.2024; : e072686. CrossRef Efficacy and safety of intragastric balloon for obesity in Korea
Kwang Gyun Lee, Seung-Joo Nam, Hyuk Soon Choi, Hang Lak Lee, Jai Hoon Yoon, Chan Hyuk Park, Kyoung Oh Kim, Do Hoon Kim, Jung-Wook Kim, Won Sohn, Sung Hoon Jung
Clinical Endoscopy.2023; 56(3): 333. CrossRef Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities
Jing Li, Hongli Duan, Yan Liu, Lu Wang, Xing Zhou
Pharmaceutics.2022; 14(7): 1445. CrossRef Anorectic interaction and safety of 5-hydroxytryptophan/carbidopa plus phentermine or diethylpropion in rat
Ernesto Limón-Bernal, José E. Roa-Coria, Ángel Zúñiga-Romero, Juan C. Huerta-Cruz, Irma R.C. Ruíz-Velasco, Francisco J. Flores-Murrieta, Eleazar Lara-Padilla, Juan G. Reyes-García, Héctor I. Rocha-González
Behavioural Pharmacology.2021; 32(5): 368. CrossRef Randomized trial of a novel lifestyle intervention compared with the Diabetes Prevention Program for weight loss in adult dependents of military service members
Sai Krupa Das, Asma S Bukhari, Amy G Taetzsch, Amy K Ernst, Gail T Rogers, Cheryl H Gilhooly, Adrienne Hatch-McChesney, Caroline M Blanchard, Kara A Livingston, Rachel E Silver, Edward Martin, Susan M McGraw, Meghan K Chin, Taylor A Vail, Laura J Lutz, Sc
The American Journal of Clinical Nutrition.2021; 114(4): 1546. CrossRef Clinical outcomes associated with anti‐obesity medications in real‐world practice: A systematic literature review
Nadia N. Ahmad, Susan Robinson, Tessa Kennedy‐Martin, Jiat Ling Poon, Hong Kan
Obesity Reviews.2021;[Epub] CrossRef Weight Loss at First Month and Development of Tolerance as Possible Predictors of 30 mg Phentermine Efficacy at 6 Months
Héctor Isaac Rocha-González, Lidia Elizabeth De la Cruz-Álvarez, Ashuin Kammar-García, Samuel Canizales-Quinteros, Juan Carlos Huerta-Cruz, Lina Marcela Barranco-Garduño, Juan Gerardo Reyes-García
Journal of Personalized Medicine.2021; 11(12): 1354. CrossRef Effects of Gambisan in overweight adults and adults with obesity
Dae-Hyun Jo, Seunghoon Lee, Jae-Dong Lee
Medicine.2019; 98(47): e18060. CrossRef Determination of phentermine, N -hydroxyphentermine and mephentermine in urine using dilute and shoot liquid chromatography–tandem mass spectrometry
Yun Jeong Choi, Arum Sim, Min Kyung Kim, Sunglll Suh, Moon Kyo In, Jin Young Kim
Journal of Chromatography B.2016; 1029-1030: 22. CrossRef Greater hunger and less restraint predict weight loss success with phentermine treatment
Elizabeth A. Thomas, Bryan Mcnair, Jamie L. Bechtell, Annie Ferland, Marc‐Andre Cornier, Robert H. Eckel
Obesity.2016; 24(1): 37. CrossRef Can we win the war on obesity with pharmacotherapy?
Juliet D. Gotthardt, Nicholas T. Bello
Expert Review of Clinical Pharmacology.2016; 9(10): 1289. CrossRef Comments on Statistical Issues in November 2013
Yong Gyu Park
Korean Journal of Family Medicine.2013; 34(6): 434. CrossRef
|